Oncotarget (@oncotarget) 's Twitter Profile
Oncotarget

@oncotarget

Oncotarget is a peer-reviewed, open-access biomedical journal indexed in MEDLINE, PubMed, PMC, Scopus, and more.

ID: 702864980362702849

linkhttp://www.oncotarget.com calendar_today25-02-2016 14:37:24

12,12K Tweet

3,3K Takipçi

3,3K Takip Edilen

Oncoscience (@oncosciencejrnl) 's Twitter Profile Photo

#OncoscienceShort: 👀 Abstract #video about this #research paper #published in Volume 12, titled "Integrating molecular diagnostics for early prostate cancer detection." 🔗 doi.org/10.18632/oncos… #cancer #prostatecancer #oa #peerreview #journal #publishing #trendingwithimpact

Oncoscience (@oncosciencejrnl) 's Twitter Profile Photo

#PaperoftheDay: "Genomic landscape of inflammatory breast cancer identifies potential actionable genetic alterations" DOI ⬇️ doi.org/10.18632/oncos… #cancer #oncology #research #openaccess #publishing #peerreviewed #journal

Oncoscience (@oncosciencejrnl) 's Twitter Profile Photo

👀 Watch and #subscribe to the Oncoscience #YouTube channel for author #interviews and #video shorts. youtube.com/channel/UCyuhJ… #research

Oncotarget (@oncotarget) 's Twitter Profile Photo

👀 Watch video #interviews from outstanding Oncotarget #authors: 🎥 oncotarget.com/videos/intervi… #research #videos #publishing

Oncotarget (@oncotarget) 's Twitter Profile Photo

✅ Read a #blog summary of the #review titled, "Advancements in bladder cancer treatment: The synergy of radiation and immunotherapy," #published in Volume 16. #Summary ⬇️ oncotarget.org/2025/06/16/exp… #cancer #bladdercancer #radiation #immunotherapy #trendingwithimpact #openaccess

Aging-US (@agingjrnl) 's Twitter Profile Photo

Honoring the Life and Legacy of Dr. Mikhail (Misha) Blagosklonny: A pioneer in #aging and #cancer research whose work transformed the field. His #legacy will continue to inspire. Learn more about his extraordinary contributions: 🔗 aging-us.com/mikhail-blagos… #geroscience #research

Honoring the Life and Legacy of Dr. Mikhail (Misha) Blagosklonny:
A pioneer in #aging and #cancer research whose work transformed the field. His #legacy will continue to inspire.

Learn more about his extraordinary contributions:
🔗 aging-us.com/mikhail-blagos…

#geroscience #research
Oncotarget (@oncotarget) 's Twitter Profile Photo

Oncotarget's Special Collection on Pancreatic Cancer: oncotarget.com/collections/pa… #pancreaticcancer #cancerresearch #cancer #collections #openacess #publishing

Oncoscience (@oncosciencejrnl) 's Twitter Profile Photo

#PaperoftheDay: "Fragile site instability: measuring more than breaks" DOI ⬇️ doi.org/10.18632/oncos… #cancer #oncology #research #openaccess #publishing #peerreviewed #journal

Oncotarget (@oncotarget) 's Twitter Profile Photo

#PaperoftheDay: "Optimizing enfortumab vedotin plus pembrolizumab therapy" DOI ⬇️ doi.org/10.18632/oncot… #cancer #research #oncology #openaccess #peerreview #journal #publishing

Oncotarget (@oncotarget) 's Twitter Profile Photo

Oncotarget's Special Collection on Breast Cancer: oncotarget.com/collections/br… #breastcancer #cancerresearch #openaccess #publishing

Oncotarget (@oncotarget) 's Twitter Profile Photo

🔆 #PaperSpotlight: This #review was recently #published in Volume 16, entitled "Beyond DNA damage response: Immunomodulatory attributes of CHEK2 in solid tumors." #PressRelease ⬇️ oncotarget.com/news/pr/chek-i… #cancer #DNA #tumors #openaccess #peerreview #journal #publishing #press

Oncotarget (@oncotarget) 's Twitter Profile Photo

#OncotargetShort: 👀 Abstract #video about this #review recently #published in Volume 16, titled "Beyond DNA damage response: Immunomodulatory attributes of CHEK2 in solid tumors." Northwestern Feinberg School of Medicine youtube.com/watch?v=C26pEB… #cancer #DNA #tumors #research #paperspotlight #oa

Oncotarget (@oncotarget) 's Twitter Profile Photo

🎧 Listen to our #pressrelease about the #review, titled "Beyond DNA damage response: Immunomodulatory attributes of CHEK2 in solid tumors." soundcloud.com/oncotarget/che… #cancer #DNA #tumors #soundcloud #podcast #audio #paperspotlight #openaccess #journal #publishing #press

Oncotarget (@oncotarget) 's Twitter Profile Photo

🔆 #PaperSpotlight: A new #review was #published on June 10, titled “Beyond DNA damage response: Immunomodulatory attributes of CHEK2 in solid tumors.” @nufeinbergmed 🔗 doi.org/10.18632/oncot… #cancer #quote #DNA #tumors #oncology #oa #peerreview #journal #publishing #meded

🔆 #PaperSpotlight:
A new #review was #published on June 10, titled “Beyond DNA damage response: Immunomodulatory attributes of CHEK2 in solid tumors.” @nufeinbergmed

🔗 doi.org/10.18632/oncot…

#cancer #quote #DNA #tumors #oncology #oa #peerreview #journal #publishing #meded
Oncotarget (@oncotarget) 's Twitter Profile Photo

🌐 Visit Oncotarget.net for insight from our distinguished #authors and for the latest #pressreleases by Oncotarget. #openaccess #peerreviewed #oncology #cancer #researchpapers #science #medicine #medEd #OA #press

Oncotarget (@oncotarget) 's Twitter Profile Photo

💬 How to #contact Oncotarget: oncotarget.com/contact/ #openaccess #openscience #peerreviewed #journalpublication #research #researchpapers #cancer #oncology #meded #publishing

Oncotarget (@oncotarget) 's Twitter Profile Photo

✅ Read a #blog summary about this #research paper #published in Volume 15: "Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia." #Summary ⬇️ oncotarget.org/2024/05/23/com… #aml

Oncotarget (@oncotarget) 's Twitter Profile Photo

Currently more than 26,000 Oncotarget papers are searchable on #PubMed: pubmed.ncbi.nlm.nih.gov/?term=oncotarg… #publishing #cancer #research #openaccess #peerreviewed #journalpublication

Oncotarget (@oncotarget) 's Twitter Profile Photo

📰 Read the latest Oncotarget #announcements and #pressreleases: oncotarget.com/news/pr/ #openaccess #peerreviewed #oncology #cancer #researchpapers

Oncotarget (@oncotarget) 's Twitter Profile Photo

✅ Read this #blog summary about the #research paper from Volume 15, titled "Prevalence and impact of the KIT M541L variant in patients with mastocytosis." #Summary ⬇️ oncotarget.org/2025/01/15/mas… #cancer #mastocytosis #skin #cells #trendingwithimpact #openaccess #publishing #meded